Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001239321 | SCV001412190 | likely benign | not provided | 2025-01-12 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002484306 | SCV002784924 | uncertain significance | Autosomal recessive nonsyndromic hearing loss 23; Usher syndrome type 1D; Usher syndrome type 1F | 2022-04-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003263878 | SCV003944892 | uncertain significance | Inborn genetic diseases | 2023-04-25 | criteria provided, single submitter | clinical testing | The c.1517C>T (p.T506M) alteration is located in exon 13 (coding exon 12) of the PCDH15 gene. This alteration results from a C to T substitution at nucleotide position 1517, causing the threonine (T) at amino acid position 506 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001828916 | SCV002088700 | uncertain significance | Usher syndrome type 1F | 2020-01-29 | no assertion criteria provided | clinical testing |